Role of dietary iron restriction in a mouse model of Parkinson's disease

Experimental Neurology

Volumn 190, Issue 2, 2004, Pages 506-514

  Levenson, Cathy W ^a,b   Cutler, Roy G ^a   Ladenheim, Bruce ^c   Cadet, Jean L ^c   Hare, Joan ^b   Mattson, Mark P ^a  

^a NATIONAL INSTITUTE ON AGING   (United States)

^b FLORIDA STATE UNIVERSITY   (United States)

^c NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

Author keywords

Apoptosis; Desferrioxiamine; Iron deficiency; MPTP; p53; Parkinson's disease; Striatum

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; CERAMIDE; DOPAMINE; IRON; PROTEIN P53; SODIUM CHLORIDE; SPHINGOMYELIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BINDING AFFINITY; CELL DAMAGE; CELL SURVIVAL; CONTROLLED STUDY; DIET RESTRICTION; DOPAMINERGIC NERVE CELL; FEEDING; IN VITRO STUDY; IRON RESTRICTION; LOCOMOTION; MALE; MOUSE; NEUROPROTECTION; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL;

ANIMALS; APOPTOSIS; CELLS, CULTURED; CERAMIDES; CORPUS STRIATUM; DOPAMINE; IMMUNOHISTOCHEMISTRY; IRON, DIETARY; MALE; MICE; MICROSCOPY, CONFOCAL; MOTOR ACTIVITY; MPTP POISONING; NEURONS; SPHINGOMYELINS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 8644283779     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.expneurol.2004.08.014     Document Type: Article

References (44)

1. P. Arosio, S. Levi, P. Santambrogio, A. Cozzi, A. Luzzago, G. Cesareni, and A. Albertini Structural and functional studies of human ferritin H and L chains Curr. Stud. Hematol. Blood Transfus. 58 1991 127 131
2. C.G. Ballard, J. O'Brien, K. Lowery, G.A. Ayre, R. Harrison, R. Perry, P. Ince, D. Neill, and I.G. McKeith A prospective study of dementia with Lewy bodies Age Ageing 27 1998 631 636
3. J. Beard Iron deficiency alters brain development and functioning J. Nutr. 133 5 Suppl. 1 2003 1468S 1472S
4. J.L. Beard, K.M. Erikson, and B.C. Jones Neurobehavioral analysis of developmental iron deficiency in rats Behav. Brain Res. 34 2002 517 524
5. J. Beard, K.M. Erikson, and B.C. Jones Neonatal iron deficiency results in irreversible changes in dopamine function in rats J. Nutr. 133 2003 1174 1179
6. D. Berg, C. Grote, W.D. Rausch, M. Maurer, W. Wesemann, P. Riederer, and G. Becker Iron accumulation in the substantia nigra in rats visualized by ultrasound Ultrasound Med. Biol. 25 1999 901 904
7. R.G. Cutler, W.A. Pedersen, S. Camandola, J.D. Rothstein, and M.P. Mattson Evidence that accumulation of ceramides and cholesterol esters mediates oxidative stress-induced death of motor neurons in amyotrophic lateral sclerosis Ann. Neurol. 52 2002 448 457
8. S.M. Day, D. Duquaine, L.V. Mundada, R.G. Menon, B.V. Khan, S. Rajagopalan, and W.P. Fay Chronic iron administration increases vascular oxidative stress and accelerates arterial thrombosis Circulation 107 2003 2601 2606
9. J.L. Derstine, L.E. Murray-Kolb, S. Yu-Poth, R.L. Hargrove, P.M. Kris-Etherton, and J.L. Beard Iron status in association with cardiovascular disease risk in 3 controlled feeding studies Am. J. Clin. Nutr. 77 2003 56 62
10. D.T. Dexter, F.R. Wells, F. Agid, Y. Agid, A.J. Lees, P. Jenner, and C.D. Marsden Increased nigral iron content in postmortem parkinsonian brain Lancet 2 1987 1219 1220
11. W. Duan, X. Zhu, B. Ladenheim, Q.S. Yu, Z. Guo, J. Oyler, R.G. Cutler, J.L. Cadet, N.H. Greig, and M.P. Mattson p53 inhibitors preserve dopamine neurons and motor function in experimental parkinsonism Ann. Neurol. 52 2002 597 606
12. E.M. Erickson, B.C. Jones, and J.L. Beard Iron deficiency alters dopamine transporter functioning in rat striatum J. Nutr. 130 2000 2831 2837
13. E.M. Erickson, B.C. Jones, E.J. Hess, Q. Zhang, and J.L. Beard Iron deficiency decreases D1 and D2 receptors in rat brain Pharm. Biochem. Behav. 69 2001 409 418
14. D.J. Fleming, K.L. Tucker, P.F. Jacques, G.E. Dallal, P.W. Wilson, and R.J. Wood Dietary factors associated with the risk of high iron stores in the elderly Framingham Heart Study cohort Am. J. Clin. Nutr. 76 2002 1375 1384
15. Y. Goodman, M.R. Steiner, S.M. Steiner, and M.P. Mattson Nordihydroguaiaretic acid protects hippocampal neurons against amyloid beta-peptide toxicity, and attenuates free radical and calcium accumulation Brain Res. 654 1994 171 176
16. J.M. Gorell, R.J. Ordidge, G.G. Brown, J.C. Deniau, N.M. Buderer, and J.A. Helpern Increased iron-related MRI contrast in the substantia nigra in Parkinson's disease Neurology 45 1995 1138 1143
17. L.A. Green, and A.S. Tischler Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor Proc. Natl. Acad. Sci. U. S. A. 73 1976 2424 2428
18. E. Grunblatt, S. Mandel, T. Berkuzki, and M.B. Youdim Apomorphine protects against MPTP-induced neurotoxicity in mice Mov. Disord. 4 1999 612 618
19. E. Grunblatt, S. Mandel, and M.B. Youdim MPTP and 6-hydroxydopamine- induced neurodegeneration as models for Parkinson's disease: neuroprotective strategies J. Neurol. 247 2000 SII95 SII102
20. E. Grunblatt, S. Mandel, G. Maor, and M.B. Youdim Effects of R- and S-apomorphine on MPTP-induced nigro-striatal dopamine neuronal loss J. Neurochem. 77 2001 146 156
21. Z. Guo, A. Ersoz, D.A. Butterfield, and M.P. Mattson Beneficial effects of dietary restriction on cerebral cortical synaptic terminals: preservation of glucose and glutamate transport and mitochondrial function after exposure to amyloid beta-peptide, iron, and 3-nitropropionic acid J. Neurochem. 75 2000 314 320
22. Y. He, P.S. Thong, T. Lee, S.K. Leong, B.Y. Mao, F. Dong, and F. Watt Dopaminergic cell death precedes iron elevation in MPTP-injected monkeys Free Radical Biol. Med. 35 2003 540 547
23. A.L. Heath, and S.J. Fairweather-Tait Health implications of iron overload: the role of diet and genotype Nutr. Rev. 61 2003 45 62
24. C. Iribarren, C.T. Sempos, J.H. Eckfeldt, and A.R. Folsom Lack of association between ferritin level and measures of LDL oxidation: the ARIC study. Atherosclerosis Risk in Communities Atherosclerosis 139 1998 189 195
25. D. Kaur, F. Yantiri, S. Rajagopalan, J. Kumar, J.Q. Mo, R. Boonplueang, V. Viswanath, R. Jacobs, L. Yang, M.F. Beal, D. DiMonte, I. Volitaskis, L. Ellerby, R.A. Cherny, A.I. Bush, and J.K. Andersen Genetic or pharmacological iron chelation prevents MPTP-induced neurotoxicity in vivo: a novel therapy for Parkinson's disease Neuron 37 2003 899 909
26. C.W. Levenson, and N.M. Tassabehji Iron and ageing: an introduction to iron regulatory mechanisms Ageing Res. Rev. 3 2004 251 263
27. G. Logroscino, K. Marder, J. Graziano, G. Freyer, V. Slavkovich, N. LoIacono, L. Cote, and R. Mayeux Altered systemic iron metabolism in Parkinson's disease Neurology 49 1997 714 717
28. G. Logroscino, K. Marder, J. Graziano, G. Freyer, V. Slavkovich, N. Lojacono, L. Cote, and R. Mayeux Dietary iron, animal fats, and risk of Parkinson's disease Mov. Disord. 13 1998 S13 S16
29. B. Lozoff, and G.M. Brittenham Behavioral aspects of iron deficiency Prog. Hematol. 14 1986 23 53
30. B. Lozoff, I. De Andraca, M. Castillo, J.B. Smith, T. Walter, and P. Pino Behavioral and developmental effects of preventing iron-deficiency anemia in healthy full-term infants Pediatrics 112 2003 846 854
31. M.P. Mattson, S.W. Barger, J.G. Begley, R.J. Mark, M.P. Mattson, S.W. Barger, J.G. Begley, and R.J. Mark Calcium, free radicals, and excitotoxic neuronal death in primary cell culture Methods Cell Biol. 46 1995 187 216
32. W.M. McDonald, I.H. Richard, and M.R. DeLong Prevalence, etiology, and treatment of depression in Parkinson's disease Biol. Psychiatry 54 1996 363 375
33. H. Mochizuki, H. Imai, K. Endo, K. Yokomizo, Y. Murata, N. Hattori, and Y. Mizuno Iron accumulation in the substantia nigra of 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridine (MPTP)-induced hemiparkinsonian monkeys Neurosci. Lett. 168 1994 251 253
34. R.L. Nelson Iron and colorectal cancer risk: human studies Nutr. Rev. 59 2001 140 148
35. S. Przedborski, and V. Jackson-Lewis Mechanisms of MPTP toxicity Mov. Disord. 13 1998 S35 S38
36. Y. Shen, and E. White p53-dependent apoptosis pathways Adv. Cancer Res. 82 2001 55 84
37. E. Sofic, P. Riederer, H. Heinsen, H. Beckmann, G.P. Reynolds, G. Hebenstreit, and M.B. Youdim Increased iron (III) and total iron content in post mortem substantia nigra of parkinsonian brain J. Neural Transm. 74 1988 199 205
38. V.N. Uversky, J. Li, and A.L. Fink Metal-triggered structural transformations, aggregation, and fibrillation of human alpha-synuclein. A possible molecular NK between Parkinson's disease and heavy metal exposure J. Biol. Chem. 276 2001 44284 44296
39. J.W. VanLandingham, C.A. Fitch, and C.W. Levenson Zinc inhibits the nuclear translocation of the tumor suppressor protein p53 and protects cultured human neurons from copper-induced neurotoxicity Neuromolecular Med. 1 2002 171 182
40. J.M. Wigglesworth, and H. Baum Iron dependent enzymes in the brain M.B.H Youdim Brain Iron: Neurochemical and Behavioural Aspects 1988 Taylor and Francis New York 25 66
41. M.B. Youdim, E. Grunblatt, and S. Mandel The pivotal role of iron in NF-kappa B activation and nigrostriatal dopaminergic neurodegeneration. Prospects for neuroprotection in Parkinson's disease with iron chelators Ann. N. Y. Acad. Sci. 890 1999 7 25
42. M.B. Youdim, M. Gassen, A. Gross, S. Mandel, and E. Grunblatt Iron chelating, antioxidant and cytoprotective properties of dopamine receptor agonist; apomorphine J. Neural Transm., Suppl. 58 2000 83 96
43. Z.F. Yu, M. Nikolova-Karakashian, D. Zhou, G. Cheng, E.H. Schuchman, and M.P. Mattson Pivotal role for acidic sphingomyelinase in cerebral ischemia-induced ceramide and cytokine production, and neuronal apoptosis J. Mol. Neurosci. 15 2000 85 97
44. R. Zaczek, and J.T. Coyle Rapid and simple method for measuring biogenic amines and metabolites in brain homogenates by HPLC-electrochemical detection J. Neural Transm. 53 1982 1 5